Dr. Harry V. Vinters

Dr. Vinters has published more than 700 articles, reviews and book chapters on various aspects of neuropathology, ranging from its clinical aspects to issues of molecular pathogenesis, tissue culture and animal models. He has also co-authored or edited six books, including all three editions of the widely used Neuropathology—a Reference Text of CNS Pathology (Mosby, 3d edition, 2013).

In addition to his clinical and teaching activities, he has had active research programs in several areas, including vascular dementias and the vascular component of Alzheimer disease (especially mediated through cerebral amyloid/congophilic angiopathy), neuropathologic substrates of intractable pediatric epilepsy, neurologic complications of AIDS, stroke and cerebrovascular disease—this work incorporates translational studies and investigation of animal models.

Notable Achievements

In the early days of the AIDS epidemic, he had an active program in, and was among the first to characterize, the neurologic complications of HIV infection.
In 1987, his laboratory contributed to discovery of one of the first 'neurotropic' strains of HIV.
Recipient of the Research Award of the Alzheimer's Association of Los Angeles, Riverside and San Bernardino Counties (2002).
Served as Editor-in-Chief of Brain Pathology from 2000-2006.
Lead investigator on a CIRM grant to study the neurologic complications of COVID-19.
Received the Alfred Meyer Medal of the British Neuropathological Society (2017).
Received the Award for Meritorious Contributions to Neuropathology from the American Association of Neuropathologists (2017).

Dr. Vinters' laboratory has hosted numerous international scholars and trainees—many of whom have gone on to distinguished careers in their home countries. These include individuals from Japan, the Netherlands, The Philippines, Latvia and South Korea. He has served and currently serves on several editorial boards of major scientific journals, including Human Pathology.